NEURAXIS, INC. Convertible Debt
NEURAXIS, INC. (NRXS) had Convertible Debt of $3.00 million as of 2024-12-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2025-05-12
- 2024-12-31: Convertible Debt $3.00M.
- 2024-02-12: Convertible Debt $3.00M.
- 2023-12-31: Convertible Debt $3.00M.
| Period end | Convertible Debt |
|---|---|
| 2024-12-31 | $3.00M 10-Q · filed 2025-05-12 |
| 2024-02-12 | $3.00M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $3.00M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |